ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #7,050Hybrid

Cancer Management and Research

Abbreviation (ISO):CANCER MANAG RES
•
Identifier (ISSN):1179-1322(Print)
•
Publisher:Dove Medical Press Ltd.
Clarivate IF (2026)
2.6– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Management and Research

WoS Q3
13463.720182.2420192.8920203.9920213.620223.320232.520242.620252.62026
Annual Impact Factor Metric
Current (2026):2.6
Scopus SJR & RankScopus Q2
0.789
#7,050

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
82

82 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
814articles/year
99.43% Gold OA•77.3% Original Research

Aims & Scope

Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include: ◦Epidemiology, detection and screening ◦Cellular research and biomarkers ◦Identification of biotargets and agents with novel mechanisms of action ◦Optimal clinical use of existing anticancer agents, including combination therapies ◦Radiation and surgery ◦Palliative care ◦Patient adherence, quality of life, satisfaction The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.

Topics Covered (Recognized by AI)
MedicineBiologyGeneticsInternal MedicineOncology & Cancer ResearchPathologyChemistryBiochemistryOncologySurgeryCancer ResearchMathematicsImmunologyStatisticsRadiology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q3
Rank196/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank230/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.6
Articles / Year224
Total Citations40
2025
IF2.6
Articles / Year276
Total Citations651
2024
IF2.5
Articles / Year163
Total Citations747
2023
IF3.3
Articles / Year153
Total Citations1,073
2022
IF3.602
Articles / Year330
Total Citations3,470

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,050Scopus Q2SCImago Profile
Scopus Coverage:2010-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.789

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.62

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,142 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,601
3-Year Documents555
Citable Documents549

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
In warning list
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Management and Research (abbr: CANCER MANAG RES, ISSN: 1179-1322) is a peer-reviewed international scholarly journal in the field of Medicine, published by Dove Medical Press Ltd. in United States. The periodical holds a Journal Impact Factor (JIF) of 2.60, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.789 (Q2), an H-index of 82.

The journal enforces rigorous peer evaluation with an annual output of approximately 814 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,142 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Dove Medical Press Ltd.
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 15f2749e-ac57-40e0-b56a-6dd4c7675350
Database Updated: 2026-09-28